Trial Profile
Effect of recombinant human endostatin on the clinical treatment of malignant cavity effusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2017
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin
- Indications Malignant pleural effusion
- Focus Adverse reactions; Therapeutic Use
- 22 Jun 2017 New trial record